Actualités Covalent - CVGR | Actions NASDAQ | ADVFN

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Covalent (CVGR)

0,00

0,00

(0,00%)

Fermé 19 Novembre 10:00PM

Retardé de 15 minutes

0,00

0,00

(0,00%)

Après les heures de négociation: -

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Covalent Group Changes Name to Encorium Group, Inc.

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient...

Covalent Group, Inc. Announces Results of Shareholder Vote

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient...

Covalent Signs $8.2 Million in Contracts For Multinational Studies to Treat Influenza

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient...

Covalent Reports 2006 Second Quarter Financial Results; Company to Hold Conference Call at 9:00 AM on Wednesday, August 9, 2006

2006 Second Quarter Business and Other Financial Highlights ? -- Returns to profitability with net income of $670,000 or $0.05 per share ?...

Covalent Group, Inc. Announces $1.7 Million Contract For Phase 2 Clinical Trial in Atherosclerosis

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient registries for...

Covalent Group, Inc. Schedules Second Quarter Financial Results and Conference Call

Covalent Group, Inc. (Nasdaq: CVGR) ("Covalent"), a leader in the design and management of complex clinical trials and patient disease registries...

Covalent Group, Inc. Signs Contracts Totaling $1.5 Million for Clinical Studies Offering Advanced Therapeutic Approaches to Pat

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient registries for...

Covalent Group Amends Business Combination Agreement with Remedium Oy

Covalent Group, Inc. (Nasdaq: CVGR) ("Covalent"), a leader in the design and management of complex clinical trials and patient disease registries...

Covalent Group, Inc. Announces $2.1 Million of New Business Contracts; Reiterates Second Quarter Guidance

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient registries for...

Covalent Reports 2006 First Quarter Financial Results and Summary Balance Sheet Data; Company to Hold Conference Call at 9:00 A

Covalent Group, Inc. (Nasdaq: CVGR): ? Business and Financial Highlights ? -- Expects to report operating profits in Q2 2006, exclusive of any...

Covalent Group, Inc. Schedules First Quarter Financial Results and Conference Call

Covalent Group, Inc. (Nasdaq: CVGR) ("Covalent"), a leader in the design and management of complex clinical trials and patient disease registries...

Covalent Group, Inc. Signs $1 Million Contract To Conduct Phase 1 Study of Drug to Prevent/Treat Infectious Disease

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient registries for...

Covalent Group, Inc. Announces Additional New Business Contracts

Covalent Group, Inc. (Nasdaq: CVGR), a leader in the design, development, and management of complex clinical trials and patient registries for...

Covalent Group, Inc. Announces $2.1 Million Contract To Conduct Patient Disease Registry In Hospitalized Subjects With Hyponatr

Covalent Group, Inc. (Nasdaq: CVGR) today announced the signing of a $2.1 million contract to conduct a Patient Disease Registry in hospitalized...

Covalent Group, Inc. Signs $1.3 Million in Consulting and Medical Writing Contracts to Support New Drug Applications (NDA) for

Covalent Group, Inc. (Nasdaq: CVGR) announced today the signing of $1.3 million in new contracts with two different biopharmaceutical companies to...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales